ClassID:

170548

G01N2333/90 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature Enzymes; Proenzymes

Sub-classes:
Recent Application in this class:
#1
20260118359
2026-04-30

ANTIBODY AGAINST HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 P24 AND TYPE 2 P26 AND USES THEREOF

#2
20250237654
2025-07-24

METHODS OF DETECTING PROSTATE CANCER

#3
20250208131
2025-06-26

Diagnosis of Congenital Heart Block

#4
20250035543
2025-01-30

Method of Fitting the Standard Curve to Analyze the Substrate Concentration by Enzyme Catalysis

#5
20250035542
2025-01-30

Method of Fitting the Standard Curve to Analyze the Enzyme Concentration by Enzyme Catalysis

#6
20240142468
2024-05-02

PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

#7
20230393145
2023-12-07

METHOD FOR DETERMINING MORTALITY RISK OF INFECTIOUS INFLAMMATORY DISEASE ON BASIS OF CONCENTRATION OF WARS AND CYTOKINE

#8
20230280346
2023-09-07

Methods of detecting prostate cancer

#9
20230167106
2023-06-01

SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE

#10
20220341941
2022-10-27

PROTEINS TARGETING ORTHOLOGS

#11
20210285962
2021-09-16

Protein biomarkers for diseases associated with the contact activation system

#12
20210283097
2021-09-16

METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE WITH S-EQUOL

#13
20210190785
2021-06-24

Biomarkers for assessing breast cancer

#14
20210130910
2021-05-06

METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS

#15
20200399266
2020-12-24

Serine threonine kinase (AKT) degradation / disruption compounds and methods of use

#16
20200385812
2020-12-10

FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME

#17
20200309787
2020-10-01

Method for determining sensitivity of cyclin-dependent kinase 4/6 inhibitor

#18
20200200750
2020-06-25

Monoclonal antibody specifically binding to thioredoxin 1, and use thereof

#19
20180259536
2018-09-13

Proteins targeting orthologs

#20
20180231552
2018-08-16

Electrochemical Analyte Detection Apparatus and Method

#21
20180164300
2018-06-14

System, method and kit for detection of analytes by production of electrochemical species

#22
20170370913
2017-12-28

Activity assay for bond forming enzymes

#23
20170360853
2017-12-21

Gastro-Intestinal Biomarkers for Diagnosis and Therapies of Proteinopathies

#24
20170321196
2017-11-09

ANALYTICAL AND DIAGNOSTIC METHODS UTILIZING SHIGELLA FLEXNERI APYRASE

#25
20170307609
2017-10-26

Methods for Treating Sepsis and Biomarkers Related Thereto

#26
20170299592
2017-10-19

Biomarkers for assessing breast cancer

#27
20170219585
2017-08-03

Reactive oxygen species production by myeloid-derived suppressor cells as a predictor of patient response to interferon-α therapy

#28
20170067874
2017-03-09

Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same

#29
20160312298
2016-10-27

Methods and assays relating to circulating tumor cells

#30
20160231321
2016-08-11

Electrochemical analyte detection apparatus and method

#31
20160146816
2016-05-26

Tumor energy metabolism profiling

#32
20160045144
2016-02-18

Metal-oxide-semiconductor capacitor based sensor

#33
20160025733
2016-01-28

Methods of detecting prostate cancer

#34
20150330992
2015-11-19

RAPID DISCOVERY AND SCREENING OF ENZYME ACTIVITY USING MASS SPECTROMETRY

#35
20150307945
2015-10-29

FGFR3 fusion gene and pharmaceutical drug targeting same

#36
20150285801
2015-10-08

BRCA1 mutations as predictive markers for topoisomerase inhibitions

#37
20150247870
2015-09-03

Method for aiding diagnosis of Alzheimer's disease

#38
20150204882
2015-07-23

METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION

#39
20150198555
2015-07-16

Sample recognition method and biosensor using same

#40
20150192578
2015-07-09

Fluorous peptide microarray, detection process using a fluorous peptide microarray, and process of forming a fluorous peptide microarray

#41
20150064136
2015-03-05

Activation of myeloid-derived suppressor cells as a predictor of patient response to interferon-A therapy

#42
20140336065
2014-11-13

Detection of human somatic cell reprogramming

#43
20120282638
2012-11-08

METHOD FOR IMMUNOASSAY OF AUTOANTIBODY AGAINST KU86, KIT FOR USE IN SAME, AND METHOD FOR DETERMINATION OF PRIMARY HEPATOCELLULAR CARCINOMA USING SAME

#44
20120214183
2012-08-23

Methods for evaluating risk of mother's milk or food inducing an onset of atopic dermatitis, and mother's milk or food with reduced risk of inducing an onset of atopic dermatitis

#45
20120202222
2012-08-09

ENZYME FRAGMENT COMPLEMENTATION ASSAYS FOR MONITORING THE ACTIVATION OF THE VOLTAGE-GATED POTASSIUM ION CHANNEL HERG

#46
20120064542
2012-03-15

Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid

#47
20110256526
2011-10-20

Detection of human somatic cell reprogramming

#48
20100183578
2010-07-22

Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease

#49
20090026075
2009-01-29

Electrochemical Analyte Detection Apparatus and Method

#50
20070142271
2007-06-21

Mracs as modifiers of the rac pathway and methods of use

#51
20060134681
2006-06-22

Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay

#52
20060019329
2006-01-26

Method of screening for protein inhibitors and activators

#53
16859644
2024-02-20

Method of treating obesity by reversal of Na/K-Atpase inhibition